The frequency of infections in patients with juvenile idiopathic arthritis on biologic agents: 1-year prospective study

Risk of Serious Infection in Juvenile Idiopathic Arthritis Patients Associated With Tumor Necrosis Factor Inhibitors and Disease Activity in the German Biologics in Pediatric Rheumatology Registry

(2017) Ingrid Becker et al.   ARTHRITIS CARE & RESEARCH

Juvenile Idiopathic Arthritis

(2017) Kenan Barut et al.   Balkan Medical Journal

Biologic-Associated Infections in Pediatric Rheumatology

(2015) Gerd Horneff   Current Rheumatology Reports

Medically Significant Infections Are Increased in Patients With Juvenile Idiopathic Arthritis Treated With Etanercept: Results From the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study

(2015) Rebecca Davies et al.   Arthritis & Rheumatology

A prospective study comparing infection risk and disease activity in children with juvenile idiopathic arthritis treated with and without tumor necrosis factor-alpha inhibitors

(2014) Heather M. Walters et al.   CLINICAL RHEUMATOLOGY

Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study

(2013) Gerd Horneff et al.   ANNALS OF THE RHEUMATIC DISEASES

Brief Report: Incidence of Selected Opportunistic Infections Among Children With Juvenile Idiopathic Arthritis

(2013) Timothy Beukelman et al.   ARTHRITIS AND RHEUMATISM

Juvenile Idiopathic Arthritis

(2012) Peter J. Gowdie et al.   PEDIATRIC CLINICS OF NORTH AMERICA

Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis

(2011) Carol A. Wallace et al.   ARTHRITIS AND RHEUMATISM

Juvenile idiopathic arthritis

(2011) Berent Prakken et al.   LANCET

Is it safe to use anti-TNF-α agents for tuberculosis in children suffering with chronic rheumatic disease?

(2011) Omer Kilic et al.   RHEUMATOLOGY INTERNATIONAL

2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features

(2011) Timothy Beukelman et al.   ARTHRITIS CARE & RESEARCH

Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis

(2009) E. H. Giannini et al.   ARTHRITIS AND RHEUMATISM

Treatment strategies for juvenile idiopathic arthritis

(2009) Ariane Klein et al.   EXPERT OPINION ON PHARMACOTHERAPY

Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register

(2008) F H M Prince et al.   ANNALS OF THE RHEUMATIC DISEASES

Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis

(2008) Daniel J. Lovell et al.   ARTHRITIS AND RHEUMATISM

Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis

(2008) Daniel J. Lovell et al.   NEW ENGLAND JOURNAL OF MEDICINE